Navigation Links
Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team
Date:2/19/2008

NEW YORK, Feb. 19 /PRNewswire-FirstCall/ -- Cowen Group, Inc. (Nasdaq: COWN) and Cowen Healthcare Royalty Partners ("CHRP") announced today that Matthew Q. Reber has been hired as Vice President, effective immediately.

Mr. Reber is based in Connecticut and rejoins founders Gregory B. Brown, Todd C. Davis and Clarke B. Futch, the Managing Directors of CHRP, with whom he previously worked at Paul Capital Partners.

Prior to joining CHRP, Mr. Reber worked at Accretive LLC, a private investment firm. Previously, he was an associate at Paul Capital Partners in the Paul Royalty Funds, which he joined in 2005 after having been a summer associate. In addition to royalty-based investing, Matt has significant healthcare experience across a broad range of transactions, including private equity investments, public and private financings, advisory transactions and structured finance. Prior to Paul Capital Partners, Mr. Reber was an investment professional focused on the healthcare industry at Oak Hill Capital Partners and J.H. Whitney & Co. and a healthcare investment banker at Morgan Stanley.

Matt earned his MBA with honors from The Wharton School of the University of Pennsylvania, his Master of Biotechnology from The University of Pennsylvania and his BSE, magna cum laude, from Princeton University.

"We are excited to have Matt rejoin us and further strengthen our team. We are confident that his extensive experience in the health care industry, combined with his strong transactional background will enhance the capabilities and leadership of our firm," said Todd C. Davis, Co-founder and Managing Director of CHRP.

Since its inception, CHRP has continued to build and strengthen its team. In January, CHRP also announced the promotion of Paul J. Hadden to Vice President and John A. Urquhart to Associate.

About Cowen Healthcare Royalty Partners

Cowen Healthcare Royalty Partners manages an investment program that invests principally in commercial-stage biopharmaceutical products and companies. CHRP seeks to invest in companies and acquires royalty interests in end-user sales of commercial-stage, or near commercial-stage medical products such as pharmaceuticals, biotechnology products and medical devices. CHRP, based in Stamford, CT, is led by a team of investors who bring complementary skills and backgrounds to bear on the evaluation and execution of these investments.

For further information, contact:

Cowen Healthcare Royalty Partners

177 Broad St., Suite 1101

Stamford, CT 06901

(646) 562-1000

http://www.cowenroyalty.com

About Cowen Group, Inc.

Cowen Group, Inc., through Cowen and Company, LLC and Cowen International Limited, provides investment banking services, including underwriting and other capital raising solutions, equity research, sales, trading and mergers and acquisitions advice, to emerging growth companies in sectors including healthcare, technology, media and telecommunications and consumer.


'/>"/>
SOURCE Cowen Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cowen Group, Inc. and Cowen Healthcare Royalty Partners Announce Expansion of Royalty Investment Team
2. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
3. The Ensign Group, Inc. Declares Quarterly Dividend of $0.04 Per Share
4. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
5. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
6. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing
7. Senexis and O2H (Oxygen Healthcare) Announce Medicinal Chemistry Collaboration
8. APIC Statement on Need for Increased Prevention Measures for Healthcare-Associated Infections (HAIs)
9. MBF Healthcare Acquisition Corp. and Critical Homecare Solutions Holdings, Inc. to Present at the 2008 UBS Healthcare Services Conference
10. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement
11. eResearchTechnology to Present at the UBS Global Healthcare Services Conference 2008 on February 11th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... NEWPORT BEACH, Calif. , June 23, 2016 /PRNewswire/ ... offering new biological discoveries to the medical community, has ... and co-founder Matthew Nunez . "We ... provide us with the capital we need to meet ... funding will essentially provide us the runway to complete ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
(Date:6/23/2016)... SAN FRANCISCO , June 22, 2016  Amgen ... platinum sponsorship of the QB3@953 life sciences ... improve human health. The shared laboratory space at QB3@953 ... startups overcome a key obstacle for many early stage ... As part of the sponsorship, Amgen launched two "Amgen ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
Breaking Biology News(10 mins):